Cerner Corporation (CERN) Getting Somewhat Favorable Press Coverage, Analysis Finds
Media stories about Cerner Corporation (NASDAQ:CERN) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cerner Corporation earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.1440153900809 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the news articles that may have impacted Accern Sentiment’s rankings:
- Cerner Corporation (CERN) Rating Increased to Hold at BidaskClub (americanbankingnews.com)
- Global High Acuity Information Solutions Market 2017-2025 – Focus on Product, End User, and Competitive Landscape – Research and Markets (businesswire.com)
- Global High Acuity Information Solutions Market Report 2017 – Forecasts to 2025 (prnewswire.com)
- Population Health Management 2017 Global Key Players – McKesson, Cerner … (medgadget.com)
- Along with interim title, Cerner’s Illig will get interim raise (bizjournals.com)
Cerner Corporation (NASDAQ:CERN) traded up 1.40% on Friday, reaching $64.25. The company’s stock had a trading volume of 2,249,981 shares. The stock has a 50 day moving average price of $64.58 and a 200-day moving average price of $61.47. The company has a market capitalization of $21.30 billion, a price-to-earnings ratio of 32.47 and a beta of 0.95. Cerner Corporation has a 1-year low of $47.01 and a 1-year high of $69.28.
Cerner Corporation (NASDAQ:CERN) last posted its quarterly earnings results on Thursday, July 27th. The company reported $0.56 EPS for the quarter, missing the consensus estimate of $0.57 by $0.01. Cerner Corporation had a net margin of 13.47% and a return on equity of 18.18%. The company had revenue of $1.29 billion for the quarter, compared to analysts’ expectations of $1.30 billion. During the same quarter in the prior year, the firm earned $0.58 earnings per share. The company’s revenue was up 6.3% on a year-over-year basis. Equities analysts predict that Cerner Corporation will post $2.50 earnings per share for the current fiscal year.
Cerner Corporation declared that its board has approved a stock repurchase plan on Thursday, May 25th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 2.3% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s leadership believes its stock is undervalued.
Several equities analysts have weighed in on the company. J P Morgan Chase & Co reissued an “overweight” rating and set a $72.00 price target (up previously from $65.00) on shares of Cerner Corporation in a research report on Tuesday, June 6th. UBS AG restated a “neutral” rating and set a $69.00 price objective (up previously from $64.00) on shares of Cerner Corporation in a report on Tuesday, June 6th. Cantor Fitzgerald restated a “buy” rating and set a $77.00 price objective (up previously from $68.00) on shares of Cerner Corporation in a report on Monday, June 5th. Canaccord Genuity restated a “buy” rating and set a $66.00 price objective on shares of Cerner Corporation in a report on Friday, June 2nd. Finally, BidaskClub upgraded Cerner Corporation from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 27th. Sixteen analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $65.84.
COPYRIGHT VIOLATION NOTICE: “Cerner Corporation (CERN) Getting Somewhat Favorable Press Coverage, Analysis Finds” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/08/20/cerner-corporation-cern-getting-somewhat-favorable-press-coverage-analysis-finds.html.
In related news, Director Linda M. Dillman sold 4,600 shares of the company’s stock in a transaction on Monday, May 22nd. The shares were sold at an average price of $64.69, for a total value of $297,574.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Clifford W. Illig sold 118,113 shares of the company’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $62.03, for a total transaction of $7,326,549.39. Following the completion of the sale, the chairman now owns 1,229,719 shares of the company’s stock, valued at $76,279,469.57. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 248,913 shares of company stock worth $16,252,337. 13.20% of the stock is currently owned by corporate insiders.
Cerner Corporation Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Stock Ratings for Cerner Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corporation and related stocks with our FREE daily email newsletter.